---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038391"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-08-14T20:15:56+00:00"
generated_at: "2026-08-14T20:24:23.600500+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioRestorative suspends ExoCR and BioX product shipments pending regulatory review

## Summary
- Suspended all orders and shipments of ExoCR and BioX biocosmeceutical product lines effective August 7, 2026.
- Suspension pending business review and regulatory assessment of documentation, sourcing, and regulatory status.
- Company has not decided to discontinue these product lines.
- Review could result in costs, need for additional capital, and uncertainty about resuming sales.

## SEC filing metadata
- accession: 0001493152-26-038391
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-08-14T20:15:56+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/0001493152-26-038391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038391
- JSON: https://secwatch.observer/filing/0001493152-26-038391.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038391.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.